273 research outputs found
Acneiform dermatoses
Acneiform dermatoses are follicular eruptions. The initial lesion is inflammatory, usually a papule or pustule. Comedones are later secondary lesions, a sequel to encapsulation and healing of the primary abscess. The earliest histological event is spongiosis, followed by a break in the follicular epithelium. The spilled follicular contents provokes a nonspecific lymphocytic and neutrophilic infiltrate. Acneiform eruptions are almost always drug induced. Important clues are sudden onset within days, widespread involvement, unusual locations (forearm, buttocks), occurrence beyond acne age, monomorphous lesions, sometimes signs of systemic drug toxicity with fever and malaise, clearing of inflammatory lesions after the drug is stopped, sometimes leaving secondary comedones. Other cutaneous eruptions that may superficially resemble acne vulgaris but that are not thought to be related to it etiologically are due to infection (e.g. gramnegative folliculitis) or unknown causes (e.g. acne necrotica or acne aestivalis)
Successful treatment of granulomatous reactions secondary to injection of esthetic implants
In recent years, various injectable materials have come into use to
improve esthetic appearance. OBJECTIVE: We describe the clinical and
histopathologic aspects of two patients who received intradermal injections of an
unknown dermal filler and the different diagnostic tools used to identify the
unknown injected material (reflexion electron microscopy, electron dispersing
x-ray) and discuss the possibility of a metastatic granulomatous reaction in one
patient. We also describe two treatments for this complication and evaluate the
legal considerations of the use of materials that have been adulterated and/or
whose composition is unknown to the patient. METHODS: We present two patients who
developed a granulomatous foreign-body reaction after the subcutaneous injection
of an esthetic implant. We treated patient 1 with isotretinoin and 2 months later
with doxycycline. We administered isotretinoin to patient 2. RESULTS: We observed
a partial improvement in patient 1 after isotretinoin treatment and a remarkable
improvement after administration of doxycycline. In patient 2, we observed an
excellent response to isotretinoin. CONCLUSION: Isotretinoin and doxycycline,
when administered separately, seem to offer effective treatment for reactions
resulting from silicone implants. However, further studies that include a larger
number of patients and those with reactions secondary to other fillers are
clearly needed before the effectiveness of this treatment can be confirmed
Recommended from our members
BENEFIT RISK JUDGMENTS FOR PATIENTS RECEIVING RETINOIDS ON A SHORT-TERM AND LONG-TERM BASIS - PANEL DISCUSSION
Application of sebomics for the analysis of residual skin surface components to detect potential biomarkers of type-1 diabetes mellitus
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. Te images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.Metabolic imbalance in chronic diseases such as type-1 diabetes may lead to detectable perturbations in the molecular composition of residual skin surface components (RSSC). This study compared the accumulation rate and the composition of RSSC in type-1 diabetic patients with those in matched controls in order to identify potential biomarkers of the disease. Samples of RSSC were collected from the foreheads of type-1 diabetic (n = 55) and non-diabetic (n = 58) volunteers. Samples were subsequently analysed to identify individual components (sebomic analysis). There was no significant difference in the rate of accumulation of RSSC between type-1 diabetics and controls. In terms of molecular composition, 171 RSSC components were common to both groups, 27 were more common in non-diabetics and 18 were more common in type-1 diabetic patients. Statistically significant (P < 0.05) differences between diabetic and non-diabetic volunteers were observed in the recovered amounts of one diacylglyceride (m/z 594), six triacylglycerides (m/z 726-860) and six free fatty acids (m/z 271-345). These findings indicate that sebomic analysis can identify differences in the molecular composition of RSSC components between type-1 diabetic and non-diabetic individuals. Further work is required to determine the practical utility and identity of these potential biomarkers.Peer reviewedFinal Published versio
- …